News & Analysis » India

Opto Circuits Arm Gets USFDA Clearance For Its EVision

(RTTNews) - Opto Circuits (India) Ltd. said its wholly-owned subsidiary Criticare Systems Inc. had received US FDA clearance on new modular patient monitoring system??”eVision 9100.

The latest certification will enable Criticare to market and commercially distribute eVision 9100 in most part of the world, particularly in the US, which is one of the largest markets for patient monitors.

eVision is the first modular 'green' monitor that is environmentally friendly and includes trickle charge solar panel. This expandable, plug-and-play monitor measures physiological parameters of patients. It is the only modular monitoring system to include Criticater's patended Water Trap system.

As per Global Markets Direct, the global revenue for multi-parameter patient monitors is estimated to be around $2,249 million.

Multi-parameter patient monitoring devices are used to monitor more than one patient parameter. eVision 9100 will monitor parameters, such as non-invasive blood pressure, invasive blood pressure, temperature, respiratory gases, anesthetic agent gases, respiratory rate, pulse oximetry, ECG and arrhythmia and ST analysis of the ECG waveforms. The monitor will be used in critical care and preoperative units and during surgery and emergency care.

At the BSE Opto Circuits shares are now trading at Rs.283.50 up by 1.43% from the previous close.